Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News
December 4, 2025Solvay Bank Distributes $100,000 in Grants to Local Nonprofits and Church Food Pantries Through FHLBNY ProgramThrough the program partnership, twenty-five local nonprofits and church food pantries across Onondaga County were granted funding to help maintain essential operations and strengthen neighborhood resilience. |
December 2, 2025Terra Science and Education became New York Affiliate of Invention Convention WorldwideTerra Science and Education is thrilled to share that Invention Convention New York (IC-NY) has officially joined Invention Convention Worldwide as an affiliate, expanding opportunities for young innovators across our state! |